“The Safety of Interleukin-1 Receptor Antagonist (anakinra) in the Treatment of Rheumatoid Arthritis”. Reumatismo, vol. 56, no. s1, Mar. 2004, pp. 74-79, https://doi.org/10.4081/reumatismo.2004.1s.74.